Jump to content

Drilldown: Medicines

Nav

Choose a table:

Medicines (732)

Medicines > halflife

: 1-1.3 hours'"`UNIQ--ref-000001A1-QINU`"'

or Not meaningfully described

or ~27 days

Use the filters below to narrow your results.

None (2) · Amoxicillin (1) · Docusate (sodium or calcium) (1)

Amoxil, Trimox, Moxatag; mostly prescribed generically (1) · Colace (sodium), Surfak (calcium); many generics OTC (1) · Emgality (1) · Vyepti (1)

Anti-CGRP ligand monoclonal antibody (2) · [[:Category:Aminopenicillins|Aminopenicillin]] (1) · [[:Category:Beta-lactam_antibiotics|β-lactam antibiotic]] (1) · [[:Category:Penicillins|Penicillin]] (1) · [[:Category:Stool_softeners|Stool softener]] (1) · [[:Category:Surfactants|Surfactant]] (1)

None (1) · Humanized IgG1 monoclonal antibody binding CGRP peptide; IV infusion enables fastest onset of any CGRP mAb (1) · Humanized IgG4 monoclonal antibody binding CGRP peptide; prevents CGRP from activating its receptor (1) · '"`UNIQ--vote-00000199-QINU`"' Extends ampicillin's spectrum with better oral bioavailability. Susceptible to β-lactamases; clavulanate co-administration restores activity against many resistant organisms'"`UNIQ--ref-0000019A-QINU`"'. (1)

Preventive treatment of migraine in adults (1) · Preventive treatment of migraine in adults; episodic cluster headache (1) · '"`UNIQ--vote-0000019B-QINU`"', '"`UNIQ--vote-0000019C-QINU`"', '"`UNIQ--vote-0000019D-QINU`"', '"`UNIQ--vote-0000019E-QINU`"', '"`UNIQ--vote-0000019F-QINU`"', '"`UNIQ--vote-000001A0-QINU`"' (1) · '"`UNIQ--vote-00001341-QINU`"', '"`UNIQ--vote-00001342-QINU`"' (1)

100 mg IV every 3 months; may increase to 300 mg IV every 3 months (1) · 100-200 mg PO once or twice daily; pediatric weight-based (1) · 500 mg PO TID or 875 mg PO BID for most indications; 80-90 mg/kg/d divided BID in pediatric otitis media (1) · Migraine: 240 mg SC loading dose, then 120 mg SC monthly. Cluster: 300 mg SC at onset of cluster period, then monthly during cluster. (1)

100 mg/mL vial for IV infusion (1) · 120 mg/mL prefilled syringe or autoinjector (1) · 250 mg, 500 mg capsules; 500 mg, 875 mg tablets; 125, 200, 250, 400 mg/5 mL oral suspension; 775 mg ER; 50 mg/mL drops (1) · 50, 100, 250 mg capsules; 50 mg/5 mL syrup; OTC (1)

240 mg loading + 120 mg/month for migraine; 300 mg/month for cluster (1) · 3 g/d typical; higher in severe infections under specialist guidance (1) · 300 mg/quarter (1) · ~500 mg/d typical (1)

Intravenous infusion (1) · Oral (2) · rectal (1) · Subcutaneous (1)

1-3 days (1) · Effect demonstrated within 24 hours in some patients (1) · Over weeks (1) · Peak plasma at 1-2 hours; clinical effect within 24-72 hours (1)

3-month dosing interval (1) · Hours (1) · Monthly dosing (1) · ~8 hours per dose (1)

100% (IV) (1) · 75-90% (oral; minimally affected by food)'"`UNIQ--ref-000001A2-QINU`"' (1) · Local action; minimal systemic effect (1) · Not formally established (high SC) (1)

Generally considered safe.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> (1) · Generally considered safe; widely used in pregnancy and lactation.<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> (1) · Limited data; avoid (2)

OTC in US (1) · Rx (2) · [[USLegal:Prescription only|Rx-only]] in US (1)

Error in "where" parameter: the string "--" cannot be used within #cargo_query.

There are no results for this report.

Retrieved from "https://pharmacopedia.wiki/p/Special:Drilldown/Medicines"